Fact CheckerSign in

NCT07425327Completed

Validity and Reliability of the Two-minute Step Test in Hemophilia

Investigating the Validity and Reliability of the Two-minute Step Test in Patients With Hemophilia

Source: ClinicalTrials.gov · Last updated 23 Sept 2026

Brief summary (registry, in English)

The aim of our study was to evaluate the psychometric properties of the 2-minute step test in hemophilia patients, assess its intra-rater and inter-rater reliability, and evaluate its convergent validity and construct validity supported by measurements of gait, balance, and functionality.

Status (registry)
Completed
Study type
Observational
Enrollment
31 (actual)
First submitted
13 Feb 2026
Start date
25 Feb 2026
Primary completion date
25 Apr 2026
Lead sponsor
Hasan Kalyoncu University
Diseases
Haemophilia
NCT number
NCT07425327

What you commit to

  • Study type: Observational
  • Participants enrolled: 31
  • From 25 Feb 2026 to the primary completion date, 25 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have undergone surgery on the lower extremities for any reason within the last 6 months,

Other illness

  • Patients with neurological sequelae following a history of intracranial hemorrhage,
  • Patients experiencing cognitive impairment to the extent that they cannot understand the tests,

Other

  • Patients who indicate they will be unable to participate in follow-up measurements.

Who the study is looking for

  • Diagnosed with Hemophilia (A-B) by a physician,
  • Aged 6-18 years,
  • Receiving regular prophylactic treatment,
  • Inhibitor positive or negative,
  • No history of lower extremity joint bleeding within the last month,
  • Individuals who are willing to participate in the study,

Age in the registry: 6 years to 18 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hasan Kalyoncu University
Coordinator of this site? Confirm its status
GaziantepTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.